Sterile protection of monkeys against malaria after administration of interleukin-12

Nature Medicine

Volumn 3, Issue 1, 1997, Pages 80-83

  Hoffman, S L ^a   Crutcher, J M ^a   Puri, S K ^b   Ansari, A A ^c   Villinger, F ^c   Franke, E D ^a   Singh, P P ^b   Finkelman, F ^d   Gately, M K ^e   Dutta, G P ^b   Sedegah, M ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOPROPHYLAXIS; MALARIA; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MALARIA; PLASMODIUM CYNOMOLGI; PLASMODIUM YOELII; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16944364593     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0197-80     Document Type: Article

References (22)

1. World Health Organization. Malaria. WHO Fact Sheet 94, 1-3 (1995).
2. Sedegah, M., Finkelman, F. & Hoffman, S.L. Interleukin-12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91, 10700-10702 (1994).
3. Schmidt, L.H., Fradkin, R., Genther, C.S., Rossan, R.N. & Squires, W. Plasmodium cynomolgi infections in the rhesus monkey. II. Responses of sporozoite-induced infections to antimalarial drugs. Am. J. Trop. Med. Hyg. 31 (Suppl.), 646-665 (1982).
4. Nadeau, R.R., Ostrowski, C., Ni-Wu, G. & Liberato, D.J. Pharmacokinetics and pharmacodynamics of recombinant human interleukin-12 in male rhesus monkeys. J. Pharmacol. Exp. Ther. 274, 78-83 (1995).
5. Villinger, F. et al. Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear cells. Cytokine 5, 469-479 (1993).
6. Villinger, F., Brar, S.S., Mayne, A., Chikkala, N. & Ansari, A.A. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155, 3946-3954 (1995).
7. Gately, M.K. & Mulqueen, M.J. Interleukin-12: Potential clinical applications in the treatment and prevention of infectious diseases. Drugs 52 (Suppl. 2), 18-26 (1996).
8. Mellouk, S., Green, S.J., Nacy, C.A. & Hoffman, S.L. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 146, 3971-3976 (1991).
9. Mellouk, S. et al. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: Enhancement by exogenous tetrahydrobiopterin. Infect. Immun. 62, 4043-4046 (1994).
10. Maheshwari, R.K. et al. Recombinant human gamma interferon inhibits simian malaria. Infect. Immun. 53, 628-630 (1986).
11. Maheshwari, R.K. The role of cytokines in malaria infection. Bull. World Health Organ. 68 (Suppl.), 138-144 (1990).
12. Stevenson, M.M., Tam, M.F., Wolf, S.F. & Sher, A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155, 2545-2556 (1995).
13. Morris, S.C. et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152, 1047-1056 (1994).
14. Wynn, T.A., Eltoum, I., Oswald, I.P., Cheever, A.W. & Sher, A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosomo mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against eg pathology. J. Exp. Med. 179, 1551-1561 (1994).
15. Wynn, T.A., Jankovic, D., Hieny, S., Cheever, A.W. & Sher, A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154, 4701-1709 (1995).
16. D'Andrea, A. et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048 (1993).
17. Trinchieri, G. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027 (1994).
18. Ling, P. et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154, 116-127 (1995).
19. + T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either 11-2 or IL-12. J. Immunol. 152, 1141-1153 (1994).
20. Malhotra, K., Salmon, D., Le Bras, J. & Vilde, J. L. Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system. Infect. Immun. 56, 3305-3309 (1988).
21. Sarmiento, U.M. et al. Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri). Lab. Invest. 71, 862-873 (1994).
22. Puri, S. K., Maheshwari, R. K., Dutta, G. P., Friedman, R. M. & Dhar, M. M. Human interferon-gamma protects rhesus monkeys against sporozoite-induced Plasmodium cynomolgi malaria infection. J. Interferon. Res. 8, 201-206 (1988).